Heart failure in 2011: Heart failure therapyĝ€"technology to the fore

Nature Reviews Cardiology

Volumn 9, Issue 2, 2012, Pages 73-74

  McMurray, John J V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC MYOSIN ACTIVATOR; DIURETIC AGENT; HYDRALAZINE; NESIRITIDE; NEW DRUG; NITRATE; OMECAMTIV MERCARBIL; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HEALTH CARE SYSTEM; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL TECHNOLOGY; MONITOR; MORTALITY; NON INVASIVE PROCEDURE; PATIENT SELECTION; PRIORITY JOURNAL; PULMONARY ARTERY; REVIEW; RISK; RISK REDUCTION; TREATMENT OUTCOME;

CARDIAC RESYNCHRONIZATION THERAPY; DISEASE PROGRESSION; HEART FAILURE; HUMANS; RETROSPECTIVE STUDIES;

EID: 84856289968     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2011.212     Document Type: Review

References (10)

1. Goldenberg, I. et al. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J. Am. Coll. Cardiol. 58, 729-737 (2011).
2. Starling, R. C. et al. Results of the post-US Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J. Am. Coll. Cardiol. 57, 1890-1898 (2011).
3. Slaughter, M. S. et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N. Engl. J. Med. 361, 2241-2251 (2009).
4. Abraham, W. T. et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377, 658-666 (2011).
5. van Veldhuisen, D. J. et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124, 1719-1726 (2011).
6. Velazquez, E. J. et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N. Engl. J. Med. 364, 1607-1616 (2011).
7. O'Connor, C. M. et al. Effect of nesiritide in patients with acute decompensated heart failure. N. Engl. J. Med. 365, 32-43 (2011).
8. Felker, G. M. et al. Diuretic strategies in patients with acute decompensated heart failure. N. Engl. J. Med. 364, 797-805 (2011).
9. Cleland, J. G. et al. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet 378, 676-683 (2011).
10. Peterson, P. N. et al. Health literacy and outcomes among patients with heart failure. JAMA 305, 1695-1701 (2011).